The FDA and the IOM report. [N Engl J Med. 2007] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: N Engl J Med. 2007 Dec 13;357(24):2520-1; author reply 2521-2.Links

Comment on:: N Engl J Med. 2007 Sep 6;357(10):960-3.

The FDA and the IOM report.

PMID: 18077820 [PubMed - indexed for MEDLINE]

Related articles

Congress responds to the IOM drug safety report--in full.
JAMA. 2007 Nov 14; 298(18):2185-7.

[JAMA. 2007]
Sidelining safety--the FDA's inadequate response to the IOM.
N Engl J Med. 2007 Sep 6; 357(10):960-3.

[N Engl J Med. 2007]
The Institute of Medicine report on the FDA: where is the science?
Health Econ. 2007 Mar; 16(3):219-21.

[Health Econ. 2007]
ReviewPremarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety.
Clin Ther. 1998; 20 Suppl C:C12-9.

[Clin Ther. 1998]
ReviewCardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
Eur Heart J. 2007 Aug; 28(15):1904-9. Epub 2007 Jul 5.

[Eur Heart J. 2007]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

The FDA and the IOM report.The FDA and the IOM report.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show